(CTNM) Contineum Therapeutics - Performance -82.1% in 12m
CTNM performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-52.61%
#117 in Peer-Group
Rel. Strength
2.67%
#7481 in Stock-Universe
Total Return 12m
-82.05%
#187 in Peer-Group
Total Return 5y
-76.44%
#135 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 21.75 USD |
| 52 Week Low | 3.40 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 42.88 |
| Buy/Sell Signal +-5 | -2.10 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CTNM (-82.1%) vs XLV (-8.7%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
0.72% | 121% | 333% | 62.6 | 55.3 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
1.34% | 12.4% | 75.7% | 19.4 | 14.7 | 1.44 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-4.44% | -18.3% | 393% | 64.5 | 36.4 | 1.21 | 58.2% | 18.9% |
| NOVN SW Novartis |
-0.32% | 0.4% | 50.2% | 19.5 | 14.7 | 1.44 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-6.59% | 2.11% | 42.2% | 19.1 | 8.73 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-4.6% | -9.78% | 100% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| IPN PA Ipsen |
0.96% | -4.39% | 39.9% | 25.8 | 10.4 | 0.74 | -6.40% | -6.33% |
| UCB BR UCB |
5.4% | 19.5% | 57.7% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: CTNM vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for CTNM
| Total Return (including Dividends) | CTNM | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -12.12% | -1.83% | 3.54% |
| 3 Months | -8.27% | -3.24% | 16.07% |
| 12 Months | -82.05% | -8.73% | 12.18% |
| 5 Years | -76.44% | 35.53% | 107.69% |
| Trend Score (consistency of price movement) | CTNM | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -53.9% | 35.5% | 91.4% |
| 3 Months | -18% | -14.5% | 97.5% |
| 12 Months | -96.1% | -79.5% | 46.7% |
| 5 Years | -81% | 87.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th8.00 | -10.49% | -15.12% |
| 3 Month | %th16.50 | -5.20% | -20.97% |
| 12 Month | %th7.50 | -80.33% | -84.00% |
| 5 Years | %th40.50 | -75.29% | -80.87% |
FAQs
Does Contineum Therapeutics (CTNM) outperform the market?
No,
over the last 12 months CTNM made -82.05%, while its related Sector, the Health Care Sector SPDR (XLV) made -8.73%.
Over the last 3 months CTNM made -8.27%, while XLV made -3.24%.
Performance Comparison CTNM vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CTNM vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.1% | -15.7% | -76.5% | -94% |
| US NASDAQ 100 | QQQ | -4.6% | -16.4% | -78.9% | -95% |
| German DAX 40 | DAX | -3.2% | -13.7% | -87.3% | -111% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.7% | -17.1% | -80.5% | -102% |
| Hongkong Hang Seng | HSI | -4.7% | -14.6% | -98.5% | -116% |
| India NIFTY 50 | INDA | -2.4% | -12.7% | -77.9% | -79% |
| Brasil Bovespa | EWZ | 0.5% | -9.2% | -88.6% | -83% |
CTNM vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.1% | -14% | -80.7% | -106% |
| Consumer Discretionary | XLY | -4.5% | -14.7% | -67.8% | -98% |
| Consumer Staples | XLP | -2.3% | -11.4% | -77.2% | -89% |
| Energy | XLE | -2% | -11.8% | -66.3% | -80% |
| Financial | XLF | -2.8% | -14.7% | -76% | -104% |
| Health Care | XLV | -2.1% | -10.3% | -66.1% | -73% |
| Industrial | XLI | -4.5% | -16.8% | -82.4% | -104% |
| Materials | XLB | -1.5% | -13.8% | -74.3% | -83% |
| Real Estate | XLRE | -3.6% | -11.5% | -75.3% | -88% |
| Technology | XLK | -4.5% | -18.4% | -82.3% | -93% |
| Utilities | XLU | -4.9% | -14% | -79.2% | -103% |
| Aerospace & Defense | XAR | -7% | -21.3% | -97.1% | -131% |
| Biotech | XBI | -5.3% | -15.2% | -67.9% | -68% |
| Homebuilder | XHB | -2.4% | -17.6% | -63.1% | -75% |
| Retail | XRT | -2.9% | -15% | -72.3% | -87% |
CTNM vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.6% | -7.88% | -60.1% | -76% |
| Natural Gas | UNG | -8.6% | -3.6% | -52.2% | -89% |
| Gold | GLD | -4.7% | -10.5% | -94.2% | -119% |
| Silver | SLV | -6.7% | -15.8% | -93.4% | -104% |
| Copper | CPER | -5.4% | -25.7% | -95.2% | -105% |
CTNM vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.6% | -12% | -71% | -78% |
| iShares High Yield Corp. Bond | HYG | -3.7% | -13% | -74.5% | -91% |